Found 76 clinical trials
Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices
This phase II trial studies how well smoking cessation treatment plans work in tobacco-dependent cancer patients when delivered virtually as part of their cancer care in community oncology practices. Virtual information and counseling sessions may help cancer patients quit smoking.
- 5 views
- 23 Mar, 2022
- 32 locations
FDG and FDOPA PET Demonstration of Functional Brain Abnormalities
information to distinguish recurrent tumors from treatment-induced radiation changes in patients with treated brain neoplasms. This is important for improving patient outcomes by allowing treating physicians
- 9 views
- 02 Mar, 2022
- 1 location
Targeting CD276 (B7-H3) Positive Solid Tumors by 4SCAR-276
tissues. This study will evaluate the side effects and effective doses of 4SCAR-276 in treating refractory and/or recurrent tumors.
- 0 views
- 24 Jan, 2021
- 2 locations
ACTengine® IMA203 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors (ACTengine)
The study purpose is to establish the safety and tolerability of IMA203 product with or without combination with nivolumab in patients with solid tumors that express preferentially expressed antigen in melanoma (PRAME).
- 0 views
- 06 Jun, 2022
- 6 locations
Selumetinib and Olaparib in Solid Tumors
cancer that has a certain type of genetic mutation (change). It is considered investigational to use selumetinib in combination with olaparib to treat advanced or recurrent cancer. The study
- 11 views
- 26 Mar, 2022
- 1 location
Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory Meningioma
effective medical therapy. Repeat surgery or radiation therapy may be possible, but they are temporizing measures with limited durable relief. PD-L1 expression in meningioma is increased for recurrent
- 108 views
- 04 Mar, 2022
- 1 location
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
patients with ultra-high-risk pediatric solid tumors with minimal disease burden, as defined in the inclusion criteria below, can prevent and/or slow recurrent tumor formation in pediatric solid tumors and
- 0 views
- 12 Mar, 2022
- 1 location
Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel for Recurrent Glioblastoma (SC9/ABX)
surgical resection of the recurrent tumor. During that procedure and when feasible, a first test dose of the chemotherapy will be administered in the operating room after sonication (procedure of
- 25 views
- 14 Jun, 2022
- 1 location
A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer
recurrent tumor is identified and a TURBT (transurethral resection of a bladder tumor) or biopsy procedure is performed to remove it.
- 0 views
- 10 May, 2022
- 7 locations
Lorlatinib Combinations in Lung Cancer
This research study is evaluating Lorlatinib in combination with Crizotinib, Binimetinib, or TNO155 as a possible treatment for either anaplastic lymphoma kinase (ALK)-positive lung cancer or ROS1-positive lung cancer. This research study involves four study drugs. Lorlatinib Binimetinib Crizotinib TNO155
- 0 views
- 19 Mar, 2021